Ipriflavone prevents rapid bone loss, increases bone density, decreases bone fractures, reduces bone pain, increases mobility, lowers high cholesterol levels, some activity against cancer.
The recommended dosage of ipriflavone is 600 mg daily.
The liver metabolizes ipriflavone into 7-hydroxy-ipriflavone and 7-(1-carboxy-ethoxy)-isoflavone. IP and its derivatives are bound to albumin, a blood protein, and distributed to tissues throughout the body.
Gastrointestinal disturbances may be avoided by taking the ipriflavone supplement with food.
The drug interactions that are additive when taking ipriflavone include bisphosphonates, calcitonin, estrogen, selective estrogen receptor modulators.
Most soy isoflavones are classified as plant estrogens (phytoestrogens), ipriflavone does not have estrogenic activity, and does not activate any estrogen receptors in the body.
The bottom of the eye is mapped to the legs and lower half of body.
Ipriflavone may decrease lymphocyte levels. Not for those with liver disease, pregnancy/breast feeding, gastric or duodenal ulcers, kidney disease, small children.
The nutritional supplements boron, calcium, fluoride, vitamin D, vitamin K may have an additive effect when taken with ipriflavone.
Do not take ipriflavone with theophylline, azfirlukast, antipsychotics, caffeine, celecoxib, cyclobenzaprine, nifedipine, anti-inflammatories, pain relivers, tacrine, tamoxifen, warfarin.
Ipriflavone has an inhibiting effect on a liver detoxification pathway involving an enzyme known as cytochrome P450. This effect increases both the blood levels and the effects of some drugs.
All medical groups that are members of the American Medical Association will treat gay people. If you have any descrimination, you can file a complaint.All medical groups that are members of the American Medical Association will treat gay people. If you have any discrimination, you can file a complaint.
wat is a perform medical examinattions diagnose illness that treat people